Ordinary shares
underlying
outstanding
options / restricted
shares or RSUs /
other rights Exercise
granted or price
Name subscribed (US$/Share) Date of grant“) Date of expiration
Jeff Jianfeng ZHANG . . . . . . . . . . . . *(3) 18.50 May 18, 2013 May 18, 2019
*(4) 14.50 July 26, 2013 —
*(2) — July 2, 2014 July 2, 2022
*(5) 69.54 January 27, 2016 January 27, 2024
*(2) — January 27, 2016 January 27, 2024
Zhenfei LIU . . . . . . . . . . . . . . . . . . *0) 18.50 May 18, 2013 May 18, 2019
*(4) 14.50 July 26, 2013 —
*(2) — July 2, 2014 July 2, 2022
*(2) — January 27, 2016 January 27, 2024
Trudy Shan DAI . . . . . . . . . . . . . . . . *(3) 18.50 May 18, 2013 May 18, 2019
*(4) 14.50 July 26, 2013 —
*(2) — July 2, 2014 July 2, 2022
*(2) — January 27, 2016 January 27, 2024
Timothy A. STEINERT . . . . . . . . . . . *(1) 5.00 November 12, 2010 —
*0) 18.50 May 18, 2013 May 18, 2019
*(4) 14.50 July 26, 2013 —
*(2) — July 2, 2014 July 2, 2022
*(2) — January 27, 2016 January 27, 2024
Jianhang JIN . . . . . . . . . . . . . . . . . . *(1) 5.00 November 12, 2010 —
*(2) — May 3, 2011 May 3, 2017
*0) — May 11, 2012 May 11, 2018
*(4) 14.50 July 26, 2013 —
*(2) — January 27, 2016 January 27, 2024
Chris Pen-hung TUNG . . . . . . . . . . . *(5) 67.28 February 21, 2016 February 21, 2022
*(2) — February 21, 2016 February 21, 2022
Yongfu YU . . . . . . . . . . . . . . . . . . . *(2) — August 20, 2013 August 20, 2019
*(2) — November 15, 2014 November 15, 2020
*(2) — August 21, 2015 August 21, 2021
Simon Xiaoming HU. . . . . . . . . . . . . *(3) 18.50 May 18, 2013 May 18, 2019
*(4) 14.50 July 26, 2013 —
*(2) — July 2, 2014 July 2, 2022
*(2) — January 27, 2016 January 27, 2024
Sophie Minzhi WU . . . . . . . . . . . . . . *6) 18.50 May 18, 2013 May 18, 2019
*(4) 14.50 July 26, 2013 —
*(2) — July 2, 2014 July 2, 2022
*(2) — January 27, 2016 January 27, 2024
Jessie Junfang ZHENG . . . . . . . . . . . *0) 18.50 May 18, 2013 May 18, 2019
*0) — May 22, 2014 May 22, 2020
*9) — August 21, 2014 August 21, 2020
*(2) — August 21, 2015 August 21, 2021
* The options, RSUs and other rights to acquire ordinary shares in aggregate held by each of these directors and executive officers and their
afﬁliates represent less than 1% of our total outstanding shares.
166